A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy.
Ontology highlight
ABSTRACT: Dramatic improvements in cancer survival have occurred in the last decade, but the quality of life for many survivors is compromised due to severe, long-lasting, and often irreversible side effects of chemotherapy. The neurological side effects, chemotherapy induced peripheral neuropathy (CIPN) and cancer related/induced cognitive impairment (CRCI/CICI), are under-recognized and can occur after chemotherapy, immunotherapy, or radiation. The cellular mechanisms underlying these neurological side effects are poorly understood and there are no effective treatments or preventions, other than reduction or termination of cancer therapy. In our preliminary prospective, non-interventional study to examine the side effects of chemotherapy in patients with breast cancer (NCT03872141), patients with
SUBMITTER: Ibrahim EY
PROVIDER: S-EPMC9543876 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA